Advice
In the absence of a submission from the holder of the marketing authorisation:
rifaximin 200 mg film coated tablets (Xifaxanta®) is not recommended for use within NHS Scotland.
Indication under review: treatment of travellers' diarrhoea that is not associated with any of:
- Fever
- Bloody diarrhoea
- Eight or more unformed stools in the previous 24 h
- Occult blood or leucocytes in the stool.
The holder of the marketing authorisation has not made a submission to SMC regarding this product in this indication. As a result we cannot recommend its use within NHSScotland.
Download detailed advice51KB (PDF)
Medicine details
- Medicine name:
- rifaximin (Xifaxanta)
- SMC ID:
- 808/12
- Indication:
- Treatment of travellers' diarrhoea.
- Pharmaceutical company
- Norgine Ltd
- BNF chapter
- Infections
- Submission type
- Non submission
- Status
- Not recommended
- Date advice published
- 13 August 2012